Google
QTTB — Q32 BIO INC (Healthcare >> Biotechnology)
QTTB FAQ
What is QTTB's P/E ratio?
Q32 BIO INC (QTTB) currently trades at a P/E ratio of 3.71.
What is QTTB's ROE?
Q32 BIO INC reports a Return on Equity (ROE) of 71.78%.
What is QTTB's dividend yield?
Q32 BIO INC offers a dividend yield of 0.00%.
What is QTTB's Deepscope Quality Score?
Deepscope rates QTTB's overall financial quality at 69 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy QTTB?
Deepscope's AI Timing Score for QTTB is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does QTTB belong to?
Q32 BIO INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 12.19
Price
-0.45
(-3.56%)
Day Change
|
|
|---|
QTTB, the overall quality is ok ( Quality = 69) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are ok , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
61% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 94 |
| Magic Formula Rank by ROA |
51
GOOD
|
| Magic Formula Rank by ROE |
51
GOOD
|
| Magic Formula Rank by ROIC |
49
GREAT
|
| Price | 12.19 |
| PBV / Sector |
4.63 / 4.48
|
| Earning Per Share | 1.89 |
| PE / Sector |
3.71 / 16.68
GREAT
|
| PEG or PE/Growth / Sector |
-0.05 / 0.53
|
| Average 1M Daily Value |
17.08 M
GREAT
|
| Average 1W Daily Value |
11.01 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
68% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-04 09:24:21 |
| Symbol | QTTB |
| Name | Q32 BIO INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 16.96 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 214.33 / 8,483.11 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 830 Winter Street, Waltham, MA, United States, 02451
Phone: 781 999 0232
Website: https://www.q32bio.com
Sector: Healthcare >> Biotechnology
Description: Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb " CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition and a range of other indications. The company was founded in 2017 and is based in Waltham, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
